Skip to main content
SpringerLink
Log in

Improvement of quality control for steroid receptor measurements: Analysis of distributions in more than 40000 primary breast cancers

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

All French laboratories that routinely assay estradiol (ER) and progesterone (PR) receptors participate in the European EORTC quality control program based on twice-yearly analysis of 5 cytosolic preparations. This system has considerably reduced inter-laboratory variations, but does not cover all aspects of these assays. Analysis of receptor value distributions is also crucial to ensure that receptor measurements remain stable with time, independently of the laboratory and assay method. This study involved 83907 receptor assays carried out in the last 17 years by 17 laboratories belonging to the French Study Group on Tissue and Molecular Biopathology. The assays were based on radioligand binding (RLA) or immunoenzymology (EIA). For each laboratory, the medians and positivity rates were analysed according to two totally objective criteria, the patient's age and the year of assay, and according to histological grade and histological type of the tumor in order to verify the correlations classically described. Age-related distributions varied little between laboratories, compared with data published by 7 European EORTC laboratories [1]. The results remained relatively stable with time in the RLA method for ER and PR, and in the EIA method for PR. Median ER-EIA data showed a marked increase between 1987 and 1989, mainly due to changes in the quality of Abbott reagents during this period. Otherwise, this analysis confirms previous pathophysiological observations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Romain S, Lainé Bidron C, Martin PM, Magdelenat H, on behalf of the EORTC receptor study group: Steroid receptor distribution in 47892 breast cancers. A collaborative study of 7 European laboratories. Eur J Cancer 31A: 411–417, 1995

    PubMed  Google Scholar 

  2. Knight WA, Livingston RB, Gregory EJ, McGuire WL: Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671, 1977

    PubMed  Google Scholar 

  3. Pichon MF, Pallud C, Brunet M, Milgrom E: Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res 40: 3357–3360, 1980

    PubMed  Google Scholar 

  4. Paridaens R, Sylvester RJ, Ferrazzi E, Legros N, Leclercq G, Heuson JC: Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer 46: 2889–2895, 1980

    PubMed  Google Scholar 

  5. Raemaekers JM, Beex JV, Pieters GF, Smals AG, Benraad TJ, Kloppenborg PW, and the breast cancer study group: Progesterone receptor activity and the response to the first endocrine therapy in advanced breast cancer. Eur J Cancer Clin Oncol 23: 443–448, 1987

    PubMed  Google Scholar 

  6. Rose C, Thorpe SM, Andersen KW, Pedersen BoV, Mouridsen HT, Blichert-Toft M, Rasmussen BB, on behalf of the Danish Breast Cancer Cooperative Group: Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1: 16–20, 1985

    PubMed  Google Scholar 

  7. Breast Cancer Cooperative Group: Standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 9: 379–381, 1973

    Google Scholar 

  8. Breast Cancer Cooperative Group: Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16: 1513–1515, 1980

    Google Scholar 

  9. Koenders A, Thorpe SM, on behalf of the EORTC Receptor Group: Standardisation of steroid receptor assays in human breast cancer. I. Reproducibility of oestradiol and progesterone receptor assays. Eur J Cancer Clin Oncol 19: 1221–1229, 1983

    PubMed  Google Scholar 

  10. Thorpe SM, on behalf of the EORTC Receptor Group: Standardisation of steroid receptor assays in human breast cancer. II. Samples with low receptor content. Eur J Cancer Clin Oncol 19: 1467–1472, 1983

    PubMed  Google Scholar 

  11. Koenders A, Thorpe SM, on behalf of the EORTC Receptor Group: Standardisation of steroid receptor assays in human breast cancer. III. Selection of reference material for intra and inter laboratory quality control. Eur J Cancer Clin Oncol 22: 939–944, 1986

    PubMed  Google Scholar 

  12. Koenders A, Thorpe SM, on behalf of the EORTC Receptor Group: Standardisation of steroid receptor assays in human breast cancer. IV. Long term within- and between- laboratory variation of estrogen and progesterone receptor assays. Eur J Cancer Clin Oncol 22: 945–952, 1986

    PubMed  Google Scholar 

  13. Blankenstein MA, Benraad TJ: Multilaboratory assessment of tissue prognostic factors in breast cancer: the EORTC Receptor Study Group experience. Canadian J Oncol (Suppl) 3: 58–64, 1992

    Google Scholar 

  14. Thorpe SM: Interlaboratory comparison of oestrogen receptor data. Eur J Cancer 6: 730–732, 1994

    Google Scholar 

  15. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359–377, 1957

    PubMed  Google Scholar 

  16. Pujol P, Hilsenbeck SG, Chamness GC, Elledge RM: Rising levels of estrogen receptor in breast cancer over 2 decades. Cancer 74: 1601–1606, 1994

    PubMed  Google Scholar 

  17. Romain S, Formento JL, Guirou O, Francoual M, Milano G, Martin PM: Determinations of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences. Eur J Cancer 30: 740–746, 1994

    Google Scholar 

  18. Weigand R, Lynch D, Cotter D: Letter to the editor. Eur J Cancer 30: 888, 1994

    Google Scholar 

  19. Thorpe SM: Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance. Acta Oncologica 27: 1–19, 1988

    PubMed  Google Scholar 

  20. Wilking N, Rutqvist LE, Nordenskjöld B, Skoog L: Steroid receptor levels in breast cancer. Relationships with age and menopausal status. Acta Oncologica 28: 807–810, 1989

    PubMed  Google Scholar 

  21. Fernö M, Borg A, Johansson U, Norgren A, Olsson H, Ryden S, Sellberg G, Southern Swedish Breast Cancer Study Group: Estrogen and progesterone receptor analyses in more than 4000 human breast cancer samples. Acta Oncologica 29: 129–135, 1990

    PubMed  Google Scholar 

  22. Martin PM, Rolland PH, Jacquemier J, Rolland AM, Toga M: Multiple receptors in human breast cancer. III. Relationships between steroid receptors and the state of differentiation and the activity of carcinomas throughout the pathologic features. Cancer Chemother Pharmacol 2: 115–120, 1979

    PubMed  Google Scholar 

  23. Magdelénat H, Gerbault-Seyreau M, Dutrillaux B: Relationship between loss of estrogen and progesterone receptor expression and of 6q and 11q chromosome arms in breast cancer. Int J Cancer 57: 63–66, 1994

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire d'Oncologie Biologique — Biopathologie Tissulaire, APM, Faculté de Médecine Nord, Bd Pierre Dramard, 13916, Marseille Cedex 20, France

    Sylvie Romain

  2. Département de Biologie, Centre René Huguenin, St Cloud, France

    Frédérique Spyratos

  3. Laboratoire d'Oncobiologie, Centre François Baclesse, Caen, France

    Jacques Goussard

  4. Laboratoire d'Oncopharmacologie, Centre Antoine Lacassagne, Nice, France

    Jean-Louis Formento

  5. Laboratoire de Transfert, Institut Curie, Paris, France

    Henri Magdelénat

Authors
  1. Sylvie Romain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frédérique Spyratos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacques Goussard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean-Louis Formento
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Henri Magdelénat
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

behalf of the French Study Group on Tissue and Molecular Biopathology

Additional information

List of participants: J.P. Basuyau, P. Brunelle, Centre Henry Becquerel, Rouen; G. Besse, Centre Jean Perrin, Clermond Ferrand; E.M. Chambaz, M. Chedin, S. Bottari, CHRU, Grenoble; A. Daver, Centre Paul-Papin, Angers; J.C. Delarue, Institut Gustave Roussy, Villejuif; J. Goussard, Centre François Baclesse, Caen; J. Grenier, CRLCC Val d'Aurelle, Montpellier; J.C. Jardillier, A. Rallet, Institut Jean Godinet, Reims; P. Jolliet, Centre Intercommunal, Creteil; M. Lanson, P. Bougnoux, CHU Bretonneau, Tours; H. Magdelénat, Institut Curie, Paris; P.M. Martin, S. Romain, Faculté de Médecine Nord, Marseille; G. Milano, J.L. Formento, Centre Antoine Lacassagne, Nice; J.P. Peyrat, Centre Oscar Lambret, Lille; V. Quillen-Pouvreau, Centre E. Marquis, Rennes; G. Ricolleau, Centre René Gauducheau, Saint-Herblain; H. Rochefort, J.P. Brouillet, Hôpital A. de Villeneuve, Montpellier; G. Soula, P. Courrière, Centre Claudius Regaud, Toulouse; F. Spyratos, Centre René Huguenin, Saint-Cloud; J. Wafflart, Fondation Bergonié, Bordeaux.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romain, S., Spyratos, F., Goussard, J. et al. Improvement of quality control for steroid receptor measurements: Analysis of distributions in more than 40000 primary breast cancers. Breast Cancer Res Tr 41, 131–139 (1996). https://doi.org/10.1007/BF01807158

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01807158

Key words

Search

Navigation